This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us  

 




SOCIETY NEWS


More resources to understand the new kidney allocation system
AST
In addition to AST's kidney allocation policy webinar on Jan. 21, now available on demand free to AST members ($25 for non-members), UNOS offers several educational resources for understanding the new UNOS/OPTN kidney allocation system, including a new podcast entitled "The New Kidney Allocation System: What Referring Physicians Need to Know," Visit either the UNOS Transplant Pro website or OPTN's website to listen.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


OPTN disease transmission advisory committee (DTAC) develops toxoplasma screening e-learning module
AST
Screening potential heart donors for toxoplasma is suggested by the OPTN ad hoc disease transmission advisory committee as a way to enhance transplant recipient safety. This simple test can help reduce the number of unexpected donor-derived toxoplasma transmissions. Hearts from donors with toxoplasma can be successfully transplanted into recipients that do not already have the disease before transplant. Access the e-learning module here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Webinars on March 18, March 20, April 10 and April 22 — free to AST members
AST
AST has several webinars taking place in March and April, all of which are available on demand after the live air date.
  • Hepatitis C Eradication: Liver Transplant Patients and Beyond; Tuesday, March 18; register online
  • Fellows Webinar: The Future of Translational Research in Transplantation; Thursday, March 20; register online
  • Fellows Webinar: Drug Safety; Thursday, April 10; register online
  • Risk of Living Kidney Donation; Tuesday, April 22; register online

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TRANSPLANT NEWS


UNOS seeks applicants for Chief Medical Officer
TransplantPro
UNOS welcomes applications for a Chief Medical Officer, an executive-level position reporting to UNOS' Chief Executive Officer. As a member of the UNOS senior staff, the CMO serves as an expert medical and clinical resource to other UNOS staff, committee members, the government and the general public in the performance of OPTN contract requirements and other UNOS corporate initiatives.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients
Transplant Infectious Disease
The epidemiology of nontuberculous mycobacteria disease in solid organ transplant recipients is poorly defined. Authors conducted a case–control study to identify risk factors for disease, matching three control patients to each case patient by date of transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Featured Advertisers


University of Utah - Multi-Organ Transplant Surgeon

The University Of Utah Department Of Surgery is seeking applications for a faculty member to join the multi-organ transplant team at the assistant professor level. This is an opportunity to join an expanding program and a cohesive group of transplant surgeons focused on excellence. The candidate should be board certified in general surgery and have completed an ASTS approved transplantation surgery fellowship. Apply here
2013 USIEC Excellence Award Winner

OTTR is pleased to be recognized for Excellence in Software by USIEC and for receiving CIBMTR Certification. Please contact us at ottr.com to see how we can help you.


Designs for Vision

The purpose of Surgical Telescopes is to enhance or magnify an image to insure the highest quality results in surgical procedures. We take our responsibility to surgeons and their patients seriously so all of our Surgical Telescopes provide the TRUE magnification that is expected. More info


Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants
Transplantation (login required)
The correlation between histopathologic phenotypes and allograft outcomes among patients desensitized for donor-specific antibody (HLA-incompatible) is unknown. In this study, authors analyzed 1-year biopsies from desensitized recipients transplanted between 1999 and 2010 and estimated graft survival for each histologic phenotype identified.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Additive effect of pretransplant obesity, diabetes and cardiovascular risk factors on outcomes after liver transplantation
Liver Transplantation (login required)
The effects of pretransplant obesity, diabetes mellitus coronary artery disease, and hypertension on outcomes after liver transplantation are controversial. Questions have also been raised about the appropriateness of the body mass index for assessing obesity in patients with end-stage liver disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection
Transplantation (login required)
Renal transplant recipients with de novo DSA experience higher rates of rejection and worse graft survival than dDSA-free recipients. This study presents a single-center review of dDSA monitoring in a large, multi-ethnic cohort of renal transplant recipients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Severity of mitral regurgitation predicts risk of death or cardiac transplantation in children with idiopathic dilated cardiomyopathy
Pediatric Cardiology via Springer
Clinical outcomes among children with idiopathic dilated cardiomyopathy are diverse, which makes the decision as to when a patient should be listed for a cardiac transplantation challenging. This study aimed to determine echocardiographic and clinical variables that can help clinicians identify those at highest risk for death or cardiac transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    A novel organ donor facility: a decade of experience with liver donors (American Journal of Transplantation)
Impact of HLA mismatch at first kidney transplant on lifetime with graft function in young recipients (American Journal of Transplantation)
T-cell migration to vascularized organ allografts (Current Opinion in Organ Transplantation)
Banff fibrosis study: Multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies (American Journal of Transplantation)

Don't be left behind. Click here to see what else you missed.


Study: Uremic toxin development in living kidney donors
Transplantation (login required)
Emerging evidence suggests that uremic toxins, in particular indoxyl sulfate and p-cresyl sulfate, may be involved in the pathogenesis of cardiovascular disease. Despite a significant increase in IS and PCS in patients with established kidney damage, the effect of a nephrectomy in non–chronic kidney disease patients is not yet known.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought
Transplant Infectious Disease (login required)
After an outbreak of Pneumocystis pneumonia in our nephrology unit, dapsone was used as the second-line chemoprophylactic agent. Dapsone is the most common cause of drug-induced methemoglobinemia. Its prevalence is poorly described in the renal transplant population. Because dapsone is excreted by the kidneys, it has been hypothesized that the rate of MHb in these patients would be higher than previously reported. Authors aimed to describe the demographics, risk factors and presenting features of MHb in these renal transplant patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues










7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063